Cyclosporine (Ophthalmic)

130 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

130

Total Reports

Deaths Reported

770.0%

Death Rate

Active Ingredients

Cyclosporine (Ophthalmic)

Administration Routes

OphthalmicUnknownIntraocularSubcutaneous

Species Affected

Dog 129

Cat 1

Most Affected Breeds

Shih Tzu 18

Crossbred Canine/dog 12

Lhasa Apso 8

Dachshund (unspecified) 8

Terrier - West Highland White 6

Terrier - Yorkshire 5

Pug 5

Spaniel - Cocker American 5

Poodle - Miniature 4

Retriever - Labrador 4

Most Reported Reactions

Vomiting 27

Corneal ulcer 18

Lack of efficacy - NOS 16

Neurogenic keratoconjunctivitis sicca (KCS) 16

Squinting 14

Lethargy (see also Central nervous system depression in 'Neurological') 13

Ocular discharge 13

Ataxia 12

Diarrhoea 12

Abnormal Schirmer tear test 12

Emesis 11

Decreased appetite 11

Outcome Breakdown

Recovered/Normal

48 (36.9%)

Outcome Unknown

35 (26.9%)

Ongoing

33 (25.4%)

Euthanized

7 (5.4%)

Recovered with Sequela

4 (3.1%)

Died

3 (2.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.